The first experience of combined treatment of patients with diabetic macular edema and complicated cataract

Diabetic cataracts in combination with diabetic macular edema (DME) is a leading cause of vision loss i n patients with diabetes mellitus.Purpose. To evaluate the efficacy and safety of one-stage combined treatment of patients with diabetes complicated by DME and cat aract.Material and methods. This...

Full description

Bibliographic Details
Main Authors: A. V. Tereshchenko, I. G. Trifanenkova, Y. A. Sidorova, E. V. Erokhina, M. V. Okuneva, V. V. Firsova
Format: Article
Language:Russian
Published: Publishing house "Ophthalmology" 2018-11-01
Series:Офтальмохирургия
Subjects:
Online Access:https://www.ophthalmosurgery.ru/jour/article/view/441
id doaj-ab3e258c06394a33983960eeb840c0e8
record_format Article
spelling doaj-ab3e258c06394a33983960eeb840c0e82021-07-28T13:53:39ZrusPublishing house "Ophthalmology"Офтальмохирургия0235-41602312-49702018-11-0103667410.25276/0235-4160-2018-3-66-74366The first experience of combined treatment of patients with diabetic macular edema and complicated cataractA. V. Tereshchenko0I. G. Trifanenkova1Y. A. Sidorova2E. V. Erokhina3M. V. Okuneva4V. V. Firsova5The Kaluga Branch of the S. Fyodorov Eye Microsurgery Federal State Institution, KalugaThe Kaluga Branch of the S. Fyodorov Eye Microsurgery Federal State Institution, KalugaThe Kaluga Branch of the S. Fyodorov Eye Microsurgery Federal State Institution, KalugaThe Kaluga Branch of the S. Fyodorov Eye Microsurgery Federal State Institution, KalugaThe Kaluga Branch of the S. Fyodorov Eye Microsurgery Federal State Institution, KalugaThe Kaluga Branch of the S. Fyodorov Eye Microsurgery Federal State Institution, KalugaDiabetic cataracts in combination with diabetic macular edema (DME) is a leading cause of vision loss i n patients with diabetes mellitus.Purpose. To evaluate the efficacy and safety of one-stage combined treatment of patients with diabetes complicated by DME and cat aract.Material and methods. This study involved 16 patients with diabetes of the type 2 (32 eyes). The main group included 16 eyes with complicated cataracts, who underwent the simultaneously performed phacoemulsification of cataract (FEC) with IOL implantation and intravitreal implantation of the «Ozurdex» implant. The second (retrospective control) group included 16 fellow eyes, where a standard FEC with IOL implantation was performed.Results. Six months after the treatment, the main group showed a BCVA stabilization at a level 0.25±0.12 (0.1-0.4). In the  retrospective group, the BCVA decreased and reached a baseline level 0.1±0.05 (0.05-0.2), in 5 patients the BCVA became below the baseline values. In all cases in the main group, a partial resorption of «solid» exudates was observed in the macular area. Edema of the retina decreased by 102-275 microns in comparison with preoperative indicators, the average retinal thickness was 385±58 microns in fovea area. Diffuse macular edema with a deposition of «solid» exudates remained in the retrospective control group, all patients had an increase in the amount of intra-etinal hemorrhages. In 5 patients, not only an increase in the number of «solid» exudates was revealed in the dynamics, but also their spread to the fovea region, in 3 cases the exudation foci acquired the form of hyper-reflective layers. The increase in the edema height occurred in all cases by 74-144 microns, index of average retinal thickness was 598±76 microns. In 7 cases, the dynamics showed an increase in flat subfoveal detachments of the neurosensory retina.Conclusions. The complex effect of the OzurDex drug in the combined treatment of diabetic cataracts in combination with DME reduces a risk of inflammatory complications in the early postoperative period, and also provides a reduction in the height of edema and partial resorption of «solid» exudates.https://www.ophthalmosurgery.ru/jour/article/view/441diabetic macular edemacataractcombined treatmentphacoemulsification of cataractozurdex implant
collection DOAJ
language Russian
format Article
sources DOAJ
author A. V. Tereshchenko
I. G. Trifanenkova
Y. A. Sidorova
E. V. Erokhina
M. V. Okuneva
V. V. Firsova
spellingShingle A. V. Tereshchenko
I. G. Trifanenkova
Y. A. Sidorova
E. V. Erokhina
M. V. Okuneva
V. V. Firsova
The first experience of combined treatment of patients with diabetic macular edema and complicated cataract
Офтальмохирургия
diabetic macular edema
cataract
combined treatment
phacoemulsification of cataract
ozurdex implant
author_facet A. V. Tereshchenko
I. G. Trifanenkova
Y. A. Sidorova
E. V. Erokhina
M. V. Okuneva
V. V. Firsova
author_sort A. V. Tereshchenko
title The first experience of combined treatment of patients with diabetic macular edema and complicated cataract
title_short The first experience of combined treatment of patients with diabetic macular edema and complicated cataract
title_full The first experience of combined treatment of patients with diabetic macular edema and complicated cataract
title_fullStr The first experience of combined treatment of patients with diabetic macular edema and complicated cataract
title_full_unstemmed The first experience of combined treatment of patients with diabetic macular edema and complicated cataract
title_sort first experience of combined treatment of patients with diabetic macular edema and complicated cataract
publisher Publishing house "Ophthalmology"
series Офтальмохирургия
issn 0235-4160
2312-4970
publishDate 2018-11-01
description Diabetic cataracts in combination with diabetic macular edema (DME) is a leading cause of vision loss i n patients with diabetes mellitus.Purpose. To evaluate the efficacy and safety of one-stage combined treatment of patients with diabetes complicated by DME and cat aract.Material and methods. This study involved 16 patients with diabetes of the type 2 (32 eyes). The main group included 16 eyes with complicated cataracts, who underwent the simultaneously performed phacoemulsification of cataract (FEC) with IOL implantation and intravitreal implantation of the «Ozurdex» implant. The second (retrospective control) group included 16 fellow eyes, where a standard FEC with IOL implantation was performed.Results. Six months after the treatment, the main group showed a BCVA stabilization at a level 0.25±0.12 (0.1-0.4). In the  retrospective group, the BCVA decreased and reached a baseline level 0.1±0.05 (0.05-0.2), in 5 patients the BCVA became below the baseline values. In all cases in the main group, a partial resorption of «solid» exudates was observed in the macular area. Edema of the retina decreased by 102-275 microns in comparison with preoperative indicators, the average retinal thickness was 385±58 microns in fovea area. Diffuse macular edema with a deposition of «solid» exudates remained in the retrospective control group, all patients had an increase in the amount of intra-etinal hemorrhages. In 5 patients, not only an increase in the number of «solid» exudates was revealed in the dynamics, but also their spread to the fovea region, in 3 cases the exudation foci acquired the form of hyper-reflective layers. The increase in the edema height occurred in all cases by 74-144 microns, index of average retinal thickness was 598±76 microns. In 7 cases, the dynamics showed an increase in flat subfoveal detachments of the neurosensory retina.Conclusions. The complex effect of the OzurDex drug in the combined treatment of diabetic cataracts in combination with DME reduces a risk of inflammatory complications in the early postoperative period, and also provides a reduction in the height of edema and partial resorption of «solid» exudates.
topic diabetic macular edema
cataract
combined treatment
phacoemulsification of cataract
ozurdex implant
url https://www.ophthalmosurgery.ru/jour/article/view/441
work_keys_str_mv AT avtereshchenko thefirstexperienceofcombinedtreatmentofpatientswithdiabeticmacularedemaandcomplicatedcataract
AT igtrifanenkova thefirstexperienceofcombinedtreatmentofpatientswithdiabeticmacularedemaandcomplicatedcataract
AT yasidorova thefirstexperienceofcombinedtreatmentofpatientswithdiabeticmacularedemaandcomplicatedcataract
AT everokhina thefirstexperienceofcombinedtreatmentofpatientswithdiabeticmacularedemaandcomplicatedcataract
AT mvokuneva thefirstexperienceofcombinedtreatmentofpatientswithdiabeticmacularedemaandcomplicatedcataract
AT vvfirsova thefirstexperienceofcombinedtreatmentofpatientswithdiabeticmacularedemaandcomplicatedcataract
AT avtereshchenko firstexperienceofcombinedtreatmentofpatientswithdiabeticmacularedemaandcomplicatedcataract
AT igtrifanenkova firstexperienceofcombinedtreatmentofpatientswithdiabeticmacularedemaandcomplicatedcataract
AT yasidorova firstexperienceofcombinedtreatmentofpatientswithdiabeticmacularedemaandcomplicatedcataract
AT everokhina firstexperienceofcombinedtreatmentofpatientswithdiabeticmacularedemaandcomplicatedcataract
AT mvokuneva firstexperienceofcombinedtreatmentofpatientswithdiabeticmacularedemaandcomplicatedcataract
AT vvfirsova firstexperienceofcombinedtreatmentofpatientswithdiabeticmacularedemaandcomplicatedcataract
_version_ 1721270296455938048